Marco Pravetoni, PhD, with funding from The Garvey Institute for Brain Health Solutions, will lead UW Medicine’s new Center for Medication Development for Substance Use Disorders. He and collaborators in New York and New Jersey are running the first-ever opioid vaccine trial in humans in the U.S.
To fight opioid crisis, UW researchers take new shot at developing vaccine against addictive drugs
The Seattle Times | January 5, 2022